Samsung Bioepis Co Ltd
1 products tracked · names used in filings: Samsung Bioepis Co Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 29 Oct 2025🇺🇸 FDA approval
FDA approves biosimilar Denosumab-Dssb (denosumab-dssb)
Samsung Bioepis Co Ltd; BLA761392; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Denosumab-Dssb denosumab-dssb | Approved | 2025-10-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.